Bangkok--Nov 21--Francom Asia
Baxter Healthcare (Thailand) selects Zuellig Pharma to handle the distribution of medical products related to critical therapies to all hospitals nationwide
Zuellig Pharma Limited (ZPL), Thailand's leading provider of sales, marketing, information systems and logistical services to multinational healthcare and pharmaceutical companies, has announced the signing of a distribution contract with Baxter Healthcare (Thailand) Co., Ltd.
Baxter Healthcare is a global medical products and services company providing all hospitals in Thailand with critical therapies for people affected by life-threatening conditions. These products allow the treatment of patients with conditions such as cancer, trauma, hemophilia, immune deficiencies, infectious diseases, kidney disease and other disorders. Baxter's Fenwal business is also a leading provider of products and services for the collection, separation, storage and transfusion of blood and its components.
Under the agreement, Zuellig Pharma will be responsible, as of January 1st, 2002, for the distribution in Thailand of intravenous therapy and anti cancer products offered by Baxter Healthcare. Zuellig will also provide Baxter with associated warehousing, invoicing, and collection services. In addition, the contract calls for Zuellig to support Baxter Healthcare's distribution with Management Information Systems and other information technology services.
Mr. Roland Bruhin, Chief Executive of Zuellig Pharma Ltd., said: "Being appointed by a company like Baxter Healthcare is a recognition of our unrivaled commitment to customer service. Zuellig Pharma will do its utmost to help Baxter Healthcare strengthen its presence in Thailand".
Mr Suvit Teerakulchon, Baxter Country Manager, explained: "As we witness increased demand for high-quality medical products and modern therapies for people affected by life threatening conditions, this partnership with Zuellig Pharma will enable us to rationalize and improve the efficiency of our delivery system. This is certainly a big step forward for our future development."
Zuellig Pharma employs 450 people in Thailand. In Asia, the Zuellig Pharma Group is the leading pharmaceutical distributor serving over 125 multinational research-based pharmaceutical manufacturers in 16 countries.
Baxter International Inc. 2000 sales amounted to US$ 6.9 billion. The Group employs more than 42,000 people in 110 countries. In Thailand, Baxter will record a turnover of Baht 340 million in 2001.
For more information, please contact:
Khun Pattaranit Imampai Zuellig Pharma's Press Information Service
C/o Francom Asia, Tel 02 233 4338 or 39, Fax 02 236 8030
E-mail: [email protected] End.
-AN-